Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Discovery of Novel UDP-.

Journal of medicinal chemistry

Ryan MD, Parkes AL, Corbett D, Dickie AP, Southey M, Andersen OA, Stein DB, Barbeau OR, Sanzone A, Thommes P, Barker J, Cain R, Compper C, Dejob M, Dorali A, Etheridge D, Evans S, Faulkner A, Gadouleau E, Gorman T, Haase D, Holbrow-Wilshaw M, Krulle T, Li X, Lumley C, Mertins B, Napier S, Odedra R, Papadopoulos K, Roumpelakis V, Spear K, Trimby E, Williams J, Zahn M, Keefe AD, Zhang Y, Soutter HT, Centrella PA, Clark MA, Cuozzo JW, Dumelin CE, Deng B, Hunt A, Sigel EA, Troast DM, DeJonge BLM.
PMID: 34569791
J Med Chem. 2021 Oct 14;64(19):14377-14425. doi: 10.1021/acs.jmedchem.1c00888. Epub 2021 Sep 27.

This study describes a novel series of UDP-

Cite
Ryan MD, Parkes AL, Corbett D, et al. Discovery of Novel UDP-. J Med Chem. 2021;64(19):14377-14425doi: 10.1021/acs.jmedchem.1c00888.
Ryan, M. D., Parkes, A. L., Corbett, D., Dickie, A. P., Southey, M., Andersen, O. A., Stein, D. B., Barbeau, O. R., Sanzone, A., Thommes, P., Barker, J., Cain, R., Compper, C., Dejob, M., Dorali, A., Etheridge, D., Evans, S., Faulkner, A., Gadouleau, E., Gorman, T., Haase, D., Holbrow-Wilshaw, M., Krulle, T., Li, X., Lumley, C., Mertins, B., Napier, S., Odedra, R., Papadopoulos, K., Roumpelakis, V., Spear, K., Trimby, E., Williams, J., Zahn, M., Keefe, A. D., Zhang, Y., Soutter, H. T., Centrella, P. A., Clark, M. A., Cuozzo, J. W., Dumelin, C. E., Deng, B., Hunt, A., Sigel, E. A., Troast, D. M., & DeJonge, B. L. M. (2021). Discovery of Novel UDP-. Journal of medicinal chemistry, 64(19), 14377-14425. https://doi.org/10.1021/acs.jmedchem.1c00888
Ryan, M Dominic, et al. "Discovery of Novel UDP-." Journal of medicinal chemistry vol. 64,19 (2021): 14377-14425. doi: https://doi.org/10.1021/acs.jmedchem.1c00888
Ryan MD, Parkes AL, Corbett D, Dickie AP, Southey M, Andersen OA, Stein DB, Barbeau OR, Sanzone A, Thommes P, Barker J, Cain R, Compper C, Dejob M, Dorali A, Etheridge D, Evans S, Faulkner A, Gadouleau E, Gorman T, Haase D, Holbrow-Wilshaw M, Krulle T, Li X, Lumley C, Mertins B, Napier S, Odedra R, Papadopoulos K, Roumpelakis V, Spear K, Trimby E, Williams J, Zahn M, Keefe AD, Zhang Y, Soutter HT, Centrella PA, Clark MA, Cuozzo JW, Dumelin CE, Deng B, Hunt A, Sigel EA, Troast DM, DeJonge BLM. Discovery of Novel UDP-. J Med Chem. 2021 Oct 14;64(19):14377-14425. doi: 10.1021/acs.jmedchem.1c00888. Epub 2021 Sep 27. PMID: 34569791.
Copy Download .nbib Format: NLM
Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography.

Cancers

Uhlig J, Leha A, Delonge LM, Haack AM, Shuch B, Kim HS, Bremmer F, Trojan L, Lotz J, Uhlig A.
PMID: 33081400
Cancers (Basel). 2020 Oct 16;12(10). doi: 10.3390/cancers12103010.

This study evaluates the diagnostic performance of radiomic features and machine learning algorithms for renal tumor subtype assessment in venous computed tomography (CT) studies from clinical routine. Patients undergoing surgical resection and histopathological assessment of renal tumors at a...

Cite
Uhlig J, Leha A, Delonge LM, et al. Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography. Cancers (Basel). 2020;12(10)doi: 10.3390/cancers12103010.
Uhlig, J., Leha, A., Delonge, L. M., Haack, A. M., Shuch, B., Kim, H. S., Bremmer, F., Trojan, L., Lotz, J., & Uhlig, A. (2020). Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography. Cancers, 12(10), . https://doi.org/10.3390/cancers12103010
Uhlig, Johannes, et al. "Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography." Cancers vol. 12,10 (2020). doi: https://doi.org/10.3390/cancers12103010
Uhlig J, Leha A, Delonge LM, Haack AM, Shuch B, Kim HS, Bremmer F, Trojan L, Lotz J, Uhlig A. Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography. Cancers (Basel). 2020 Oct 16;12(10). doi: 10.3390/cancers12103010. PMID: 33081400; PMCID: PMC7603020.
Copy Download .nbib Format: NLM
Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan.

Influenza and other respiratory viruses

DeJonge PM, Monto AS, Malosh RE, Petrie JG, Segaloff HE, McSpadden E, Cheng C, Bazzi L, Callear A, Johnson E, Truscon R, Martin ET.
PMID: 34821476
Influenza Other Respir Viruses. 2021 Nov 25; doi: 10.1111/irv.12944. Epub 2021 Nov 25.

INTRODUCTION: In Southeast Michigan, active surveillance studies monitor influenza activity in hospitals, ambulatory clinics, and community households. Across five respiratory seasons, we assessed the contribution of data from each of the three networks towards improving our overall understanding of...

Cite
DeJonge PM, Monto AS, Malosh RE, et al. Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan. Influenza Other Respir Viruses. 2021;doi: 10.1111/irv.12944.
DeJonge, P. M., Monto, A. S., Malosh, R. E., Petrie, J. G., Segaloff, H. E., McSpadden, E., Cheng, C., Bazzi, L., Callear, A., Johnson, E., Truscon, R., & Martin, E. T. (2021). Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan. Influenza and other respiratory viruses, . https://doi.org/10.1111/irv.12944
DeJonge, Peter M, et al. "Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan." Influenza and other respiratory viruses vol. (2021). doi: https://doi.org/10.1111/irv.12944
DeJonge PM, Monto AS, Malosh RE, Petrie JG, Segaloff HE, McSpadden E, Cheng C, Bazzi L, Callear A, Johnson E, Truscon R, Martin ET. Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan. Influenza Other Respir Viruses. 2021 Nov 25; doi: 10.1111/irv.12944. Epub 2021 Nov 25. PMID: 34821476.
Copy Download .nbib Format: NLM
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone.

The mental health clinician

Mailloux LM, Haas MT, Larew JM, DeJongh BM.
PMID: 33505825
Ment Health Clin. 2021 Jan 08;11(1):35-39. doi: 10.9740/mhc.2021.01.035. eCollection 2021 Jan.

INTRODUCTION: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality improvement initiative is to develop and implement a PPCPM for...

Cite
Mailloux LM, Haas MT, Larew JM, et al. Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone. Ment Health Clin. 2021;11(1):35-39doi: 10.9740/mhc.2021.01.035.
Mailloux, L. M., Haas, M. T., Larew, J. M., & DeJongh, B. M. (2021). Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone. The mental health clinician, 11(1), 35-39. https://doi.org/10.9740/mhc.2021.01.035
Mailloux, Lindsay M, et al. "Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone." The mental health clinician vol. 11,1 (2021): 35-39. doi: https://doi.org/10.9740/mhc.2021.01.035
Mailloux LM, Haas MT, Larew JM, DeJongh BM. Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone. Ment Health Clin. 2021 Jan 08;11(1):35-39. doi: 10.9740/mhc.2021.01.035. eCollection 2021 Jan. PMID: 33505825; PMCID: PMC7800330.
Copy Download .nbib Format: NLM
Discovery of Novel UDP-.

Journal of medicinal chemistry

Ryan MD, Parkes AL, Corbett D, Dickie AP, Southey M, Andersen OA, Stein DB, Barbeau OR, Sanzone A, Thommes P, Barker J, Cain R, Compper C, Dejob M, Dorali A, Etheridge D, Evans S, Faulkner A, Gadouleau E, Gorman T, Haase D, Holbrow-Wilshaw M, Krulle T, Li X, Lumley C, Mertins B, Napier S, Odedra R, Papadopoulos K, Roumpelakis V, Spear K, Trimby E, Williams J, Zahn M, Keefe AD, Zhang Y, Soutter HT, Centrella PA, Clark MA, Cuozzo JW, Dumelin CE, Deng B, Hunt A, Sigel EA, Troast DM, DeJonge BLM.
PMID: 34569791
J Med Chem. 2021 Oct 14;64(19):14377-14425. doi: 10.1021/acs.jmedchem.1c00888. Epub 2021 Sep 27.

This study describes a novel series of UDP-

Cite
Ryan MD, Parkes AL, Corbett D, et al. Discovery of Novel UDP-. J Med Chem. 2021;64(19):14377-14425doi: 10.1021/acs.jmedchem.1c00888.
Ryan, M. D., Parkes, A. L., Corbett, D., Dickie, A. P., Southey, M., Andersen, O. A., Stein, D. B., Barbeau, O. R., Sanzone, A., Thommes, P., Barker, J., Cain, R., Compper, C., Dejob, M., Dorali, A., Etheridge, D., Evans, S., Faulkner, A., Gadouleau, E., Gorman, T., Haase, D., Holbrow-Wilshaw, M., Krulle, T., Li, X., Lumley, C., Mertins, B., Napier, S., Odedra, R., Papadopoulos, K., Roumpelakis, V., Spear, K., Trimby, E., Williams, J., Zahn, M., Keefe, A. D., Zhang, Y., Soutter, H. T., Centrella, P. A., Clark, M. A., Cuozzo, J. W., Dumelin, C. E., Deng, B., Hunt, A., Sigel, E. A., Troast, D. M., & DeJonge, B. L. M. (2021). Discovery of Novel UDP-. Journal of medicinal chemistry, 64(19), 14377-14425. https://doi.org/10.1021/acs.jmedchem.1c00888
Ryan, M Dominic, et al. "Discovery of Novel UDP-." Journal of medicinal chemistry vol. 64,19 (2021): 14377-14425. doi: https://doi.org/10.1021/acs.jmedchem.1c00888
Ryan MD, Parkes AL, Corbett D, Dickie AP, Southey M, Andersen OA, Stein DB, Barbeau OR, Sanzone A, Thommes P, Barker J, Cain R, Compper C, Dejob M, Dorali A, Etheridge D, Evans S, Faulkner A, Gadouleau E, Gorman T, Haase D, Holbrow-Wilshaw M, Krulle T, Li X, Lumley C, Mertins B, Napier S, Odedra R, Papadopoulos K, Roumpelakis V, Spear K, Trimby E, Williams J, Zahn M, Keefe AD, Zhang Y, Soutter HT, Centrella PA, Clark MA, Cuozzo JW, Dumelin CE, Deng B, Hunt A, Sigel EA, Troast DM, DeJonge BLM. Discovery of Novel UDP-. J Med Chem. 2021 Oct 14;64(19):14377-14425. doi: 10.1021/acs.jmedchem.1c00888. Epub 2021 Sep 27. PMID: 34569791.
Copy Download .nbib Format: NLM
Implementation and evaluation of depression screening in patients with recently diagnosed coronary artery disease.

The mental health clinician

Mailloux LM, Haas MT, Kennedy SP, DeJongh BM.
PMID: 31942273
Ment Health Clin. 2020 Jan 09;10(1):12-17. doi: 10.9740/mhc.2020.01.012. eCollection 2020 Jan.

INTRODUCTION: Patients with coronary artery disease (CAD) are at an increased risk for depression. Additionally, comorbid depression in patients with CAD is associated with increased mortality and worse cardiac outcomes. Screening this patient population for depression is recommended but...

Cite
Mailloux LM, Haas MT, Kennedy SP, et al. Implementation and evaluation of depression screening in patients with recently diagnosed coronary artery disease. Ment Health Clin. 2020;10(1):12-17doi: 10.9740/mhc.2020.01.012.
Mailloux, L. M., Haas, M. T., Kennedy, S. P., & DeJongh, B. M. (2020). Implementation and evaluation of depression screening in patients with recently diagnosed coronary artery disease. The mental health clinician, 10(1), 12-17. https://doi.org/10.9740/mhc.2020.01.012
Mailloux, Lindsay M, et al. "Implementation and evaluation of depression screening in patients with recently diagnosed coronary artery disease." The mental health clinician vol. 10,1 (2020): 12-17. doi: https://doi.org/10.9740/mhc.2020.01.012
Mailloux LM, Haas MT, Kennedy SP, DeJongh BM. Implementation and evaluation of depression screening in patients with recently diagnosed coronary artery disease. Ment Health Clin. 2020 Jan 09;10(1):12-17. doi: 10.9740/mhc.2020.01.012. eCollection 2020 Jan. PMID: 31942273; PMCID: PMC6956978.
Copy Download .nbib Format: NLM
Associations among physical activity tracking, physical activity motivation and level of physical activity in young adults.

Journal of health psychology

O'Loughlin EK, Sabiston CM, deJonge ML, Lucibello KM, O'Loughlin JL.
PMID: 33878944
J Health Psychol. 2021 Apr 20;13591053211008209. doi: 10.1177/13591053211008209. Epub 2021 Apr 20.

Whether physical activity (PA) tracking devices are associated with PA motivation in young adults is largely unknown. We compared total PA minutes per week, total minutes walking/week, meeting moderate-to vigorous PA guidelines, and past-year activity tracking across motivation cluster...

Cite
O'Loughlin EK, Sabiston CM, deJonge ML, et al. Associations among physical activity tracking, physical activity motivation and level of physical activity in young adults. J Health Psychol. 2021;13591053211008209doi: 10.1177/13591053211008209.
O'Loughlin, E. K., Sabiston, C. M., deJonge, M. L., Lucibello, K. M., & O'Loughlin, J. L. (2021). Associations among physical activity tracking, physical activity motivation and level of physical activity in young adults. Journal of health psychology, 13591053211008209. https://doi.org/10.1177/13591053211008209
O'Loughlin, Erin K, et al. "Associations among physical activity tracking, physical activity motivation and level of physical activity in young adults." Journal of health psychology vol. (2021): 13591053211008209. doi: https://doi.org/10.1177/13591053211008209
O'Loughlin EK, Sabiston CM, deJonge ML, Lucibello KM, O'Loughlin JL. Associations among physical activity tracking, physical activity motivation and level of physical activity in young adults. J Health Psychol. 2021 Apr 20;13591053211008209. doi: 10.1177/13591053211008209. Epub 2021 Apr 20. PMID: 33878944.
Copy Download .nbib Format: NLM
Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome.

The mental health clinician

DeJongh BM.
PMID: 34824956
Ment Health Clin. 2021 Nov 08;11(6):311-319. doi: 10.9740/mhc.2021.11.311. eCollection 2021 Nov.

Antipsychotic medications increase the risk of metabolic syndrome, which then increases the risk of atherosclerotic cardiovascular disease and premature death. Routinely monitoring for signs of metabolic syndrome in patients taking antipsychotics allows for early detection and intervention. Psychiatric pharmacists...

Cite
DeJongh BM. Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. Ment Health Clin. 2021;11(6):311-319doi: 10.9740/mhc.2021.11.311.
DeJongh, B. M. (2021). Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. The mental health clinician, 11(6), 311-319. https://doi.org/10.9740/mhc.2021.11.311
DeJongh, Beth M. "Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome." The mental health clinician vol. 11,6 (2021): 311-319. doi: https://doi.org/10.9740/mhc.2021.11.311
DeJongh BM. Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. Ment Health Clin. 2021 Nov 08;11(6):311-319. doi: 10.9740/mhc.2021.11.311. eCollection 2021 Nov. PMID: 34824956; PMCID: PMC8582768.
Copy Download .nbib Format: NLM
Motivation for traumatic brain injury rehabilitation questionnaire (MOT-Q): reliability, factor analysis, and relationship to MMPI-2 variables.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists

Chervinsky AB, Ommaya AK, deJonge M, Spector J, Schwab K, Salazar AM.
PMID: 14590608
Arch Clin Neuropsychol. 1998 Jul;13(5):433-46.

A Likert scale questionnaire was developed to assess motivation for postacute rehabilitation by traumatic brain injury patients. Items were designed to reflect head-injured individuals' statements about their attitudes toward head injury rehabilitation. Factors such as denial of illness, anger,...

Cite
Chervinsky AB, Ommaya AK, deJonge M, et al. Motivation for traumatic brain injury rehabilitation questionnaire (MOT-Q): reliability, factor analysis, and relationship to MMPI-2 variables. Arch Clin Neuropsychol. 1998;13(5):433-46
Chervinsky, A. B., Ommaya, A. K., deJonge, M., Spector, J., Schwab, K., & Salazar, A. M. (1998). Motivation for traumatic brain injury rehabilitation questionnaire (MOT-Q): reliability, factor analysis, and relationship to MMPI-2 variables. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 13(5), 433-46.
Chervinsky, A B, et al. "Motivation for traumatic brain injury rehabilitation questionnaire (MOT-Q): reliability, factor analysis, and relationship to MMPI-2 variables." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists vol. 13,5 (1998): 433-46.
Chervinsky AB, Ommaya AK, deJonge M, Spector J, Schwab K, Salazar AM. Motivation for traumatic brain injury rehabilitation questionnaire (MOT-Q): reliability, factor analysis, and relationship to MMPI-2 variables. Arch Clin Neuropsychol. 1998 Jul;13(5):433-46. PMID: 14590608.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries